Fact CheckerSign in

NCT07271771RecruitingPhase 4

The effect of denosumab on muscle and strength and insulin sensitivity

Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 May 2026

Brief summary (registry, in English)

Randomized, placebo controlled prospective trial evaluating the effect of denosumab on insulin sensitivity and muscle strength.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
First submitted
5 Jan 2024
Start date
21 May 2024
Lead sponsor
Region Midtjylland
Diseases
Osteoporosis
EU CT number
2024-510637-18-00

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 40
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Other antidiabetic medication than metformin
  • Ongoing treatment with systemic glucocorticoids

Other illness

  • Metabolic bone disease (for example osteogenesis imperfecta, Paget's disease of bone, hyperparathyroidism)
  • Active cancer within the last 5 years with the exception of basal cell skin cancer

Lab values

  • Treatment affecting bone, calcium metabolism or muscle
  • Estimated glomerular filtration rate (eGFR) ≤ 35 mL/min

Other

  • Treatment for osteoporosis at any time
  • Unable to read and understand Danish
  • Immobility
  • Low-energy vertebral fractures at any time
  • Low-energy hip fracture at any time

Who the study is looking for

  • Postmenopausal women (postmenopausal for at least two years)
  • Age ≥ 40 years
  • BMD T-score ≥ -2.0 (lumbar spine, total hip or femoral neck)
  • At least 2 lumbar vertebrae that can be evaluated by dual-energy x-ray absorptiometry (DXA)
  • Diabetes Mellitus type 2
  • Treatment with metformin as monotherapy

Age in the registry: 18 years to 64 years · Sex: Female · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Region Midtjylland
Coordinator of this site? Confirm its status
Aarhus NDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.